Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Liquimax
- Development stage
- Unknown
- Lead developer
- Epsilon Biotech
01
Overview
**Liquimax** is a non-specific trade name used by Epsilon Biotech for at least two different products in India. **Liquimax Cream** contains **luliconazole 1%**, a topical imidazole antifungal used for dermatophyte skin infections including tinea pedis, tinea cruris, and tinea corporis. Luliconazole inhibits fungal ergosterol biosynthesis, compromising the fungal cell membrane. Separately, **Liquimax Capsules** contain elemental calcium plus cholecalciferol and are used as a calcium and vitamin D nutritional supplement for deficiency states and bone-health support. These products are chemically and pharmacologically distinct and should not be merged as one drug entity.
- Brand names
- Liquimax
Beyond the preview
Go deeper on Liquimax.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Liquimax.